Flexray Medical ApS: Financial statements 2025
CVR: 36890509
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
Flexray Medical ApS (CVR 36890509) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 5,054,938 and a net result of DKK 2,437,076 compared with DKK 1,698,525 the year before. That is an increase of 7.7% compared with the year before. Equity in the 2025 report amounted to DKK 10,161,504. The solvency ratio was 76.7%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 5,054,938
- Profit/Loss
- DKK 2,437,076
- Equity
- DKK 10,161,504
- Total Assets
- DKK 13,241,833
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 5.1 mio. | 2.4 mio. | 10.2 mio. | 4 |
| 2024 | - | 4.7 mio. | 1.7 mio. | 8.5 mio. | 4 |
| 2023 | - | 4.3 mio. | 860 t. | 7.2 mio. | 4 |
| 2022 | - | 5.5 mio. | 2.4 mio. | 6.8 mio. | 3 |
| 2021 | - | 5.5 mio. | 2.7 mio. | 5.1 mio. | 3 |
Official annual report
How creditworthy is Flexray Medical ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Flexray Medical ApS
Flexray Medical ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Mads Vittrup and Simon Dyrup Nielsen. The company is owned by Simba Holding ApS and SDHD Holding ApS. The company has 5 employees (2026). In 2026, the company reported a gross profit of DKK 2,930,775 and a net result of DKK 733,340 compared with DKK 2,437,076 the year before. Equity in the 2026 report amounted to DKK 10,144,844.